These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 17986321)

  • 1. S100A7 (Psoriasin), highly expressed in ductal carcinoma in situ (DCIS), is regulated by IFN-gamma in mammary epithelial cells.
    Petersson S; Bylander A; Yhr M; Enerbäck C
    BMC Cancer; 2007 Nov; 7():205. PubMed ID: 17986321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of ICAM-1 signaling induces psoriasin (S100A7) and MUC1 in mammary epithelial cells.
    Petersson S; Shubbar E; Yhr M; Kovacs A; Enerbäck C
    Breast Cancer Res Treat; 2011 Jan; 125(1):13-25. PubMed ID: 20217214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psoriasin (S100A7) and calgranulin-B (S100A9) induction is dependent on reactive oxygen species and is downregulated by Bcl-2 and antioxidants.
    Carlsson H; Yhr M; Petersson S; Collins N; Polyak K; Enerbäck C
    Cancer Biol Ther; 2005 Sep; 4(9):998-1005. PubMed ID: 16082188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The expression of Psoriasin (S100A7) and CD24 is linked and related to the differentiation of mammary epithelial cells.
    Vegfors J; Petersson S; Kovács A; Polyak K; Enerbäck C
    PLoS One; 2012; 7(12):e53119. PubMed ID: 23300877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psoriasin expression in mammary epithelial cells in vitro and in vivo.
    Enerbäck C; Porter DA; Seth P; Sgroi D; Gaudet J; Weremowicz S; Morton CC; Schnitt S; Pitts RL; Stampl J; Barnhart K; Polyak K
    Cancer Res; 2002 Jan; 62(1):43-7. PubMed ID: 11782356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential role of psoriasin (S100A7) in estrogen receptor α positive and negative breast cancer cells occur through actin remodeling.
    Sneh A; Deol YS; Ganju A; Shilo K; Rosol TJ; Nasser MW; Ganju RK
    Breast Cancer Res Treat; 2013 Apr; 138(3):727-39. PubMed ID: 23535840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cluster analysis of S100 gene expression and genes correlating to psoriasin (S100A7) expression at different stages of breast cancer development.
    Carlsson H; Petersson S; Enerbäck C
    Int J Oncol; 2005 Dec; 27(6):1473-81. PubMed ID: 16273201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression patterns of S100A7 (psoriasin) and S100A9 (calgranulin-B) in keratinocyte differentiation.
    Martinsson H; Yhr M; Enerbäck C
    Exp Dermatol; 2005 Mar; 14(3):161-8. PubMed ID: 15740587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A putative role for psoriasin in breast tumor progression.
    Krop I; März A; Carlsson H; Li X; Bloushtain-Qimron N; Hu M; Gelman R; Sabel MS; Schnitt S; Ramaswamy S; Kleer CG; Enerbäck C; Polyak K
    Cancer Res; 2005 Dec; 65(24):11326-34. PubMed ID: 16357139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression analysis of the mouse S100A7/psoriasin gene in skin inflammation and mammary tumorigenesis.
    Webb M; Emberley ED; Lizardo M; Alowami S; Qing G; Alfia'ar A; Snell-Curtis LJ; Niu Y; Civetta A; Myal Y; Shiu R; Murphy LC; Watson PH
    BMC Cancer; 2005 Feb; 5():17. PubMed ID: 15717926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BRCA1 and c-Myc associate to transcriptionally repress psoriasin, a DNA damage-inducible gene.
    Kennedy RD; Gorski JJ; Quinn JE; Stewart GE; James CR; Moore S; Mulligan K; Emberley ED; Lioe TF; Morrison PJ; Mullan PB; Reid G; Johnston PG; Watson PH; Harkin DP
    Cancer Res; 2005 Nov; 65(22):10265-72. PubMed ID: 16288014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis.
    Wolk K; Witte E; Wallace E; Döcke WD; Kunz S; Asadullah K; Volk HD; Sterry W; Sabat R
    Eur J Immunol; 2006 May; 36(5):1309-23. PubMed ID: 16619290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psoriasin is aberrantly expressed in human breast cancer and is related to clinical outcomes.
    Jiang WG; Watkins G; Douglas-Jones A; Mansel RE
    Int J Oncol; 2004 Jul; 25(1):81-5. PubMed ID: 15201992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human hair follicle epithelium has an antimicrobial defence system that includes the inducible antimicrobial peptide psoriasin (S100A7) and RNase 7.
    Reithmayer K; Meyer KC; Kleditzsch P; Tiede S; Uppalapati SK; Gläser R; Harder J; Schröder JM; Paus R
    Br J Dermatol; 2009 Jul; 161(1):78-89. PubMed ID: 19416233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psoriasin interacts with Jab1 and influences breast cancer progression.
    Emberley ED; Niu Y; Leygue E; Tomes L; Gietz RD; Murphy LC; Watson PH
    Cancer Res; 2003 Apr; 63(8):1954-61. PubMed ID: 12702588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psoriasin (S100A7) expression is associated with poor outcome in estrogen receptor-negative invasive breast cancer.
    Emberley ED; Niu Y; Njue C; Kliewer EV; Murphy LC; Watson PH
    Clin Cancer Res; 2003 Jul; 9(7):2627-31. PubMed ID: 12855640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psoriasin (S100A7) increases the expression of ROS and VEGF and acts through RAGE to promote endothelial cell proliferation.
    Shubbar E; Vegfors J; Carlström M; Petersson S; Enerbäck C
    Breast Cancer Res Treat; 2012 Jul; 134(1):71-80. PubMed ID: 22189627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Signal Integration of IFN-I and IFN-II With TLR4 Involves Sequential Recruitment of STAT1-Complexes and NFκB to Enhance Pro-inflammatory Transcription.
    Piaszyk-Borychowska A; Széles L; Csermely A; Chiang HC; Wesoły J; Lee CK; Nagy L; Bluyssen HAR
    Front Immunol; 2019; 10():1253. PubMed ID: 31231385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. S100A7 (psoriasin) expression is associated with aggressive features and alteration of Jab1 in ductal carcinoma in situ of the breast.
    Emberley ED; Alowami S; Snell L; Murphy LC; Watson PH
    Breast Cancer Res; 2004; 6(4):R308-15. PubMed ID: 15217497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-29b defines the pro-/anti-proliferative effects of S100A7 in breast cancer.
    Zhao H; Wilkie T; Deol Y; Sneh A; Ganju A; Basree M; Nasser MW; Ganju RK
    Mol Cancer; 2015 Jan; 14():11. PubMed ID: 25622979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.